Detalles de la búsqueda
1.
Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.
Br J Haematol
; 204(6): 2227-2232, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38504552
2.
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN.
Am J Hematol
; 99(7): 1257-1268, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38622840
3.
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.
Br J Haematol
; 199(3): 355-365, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36111391
4.
Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone as first line of therapy in the United States.
BMC Cancer
; 22(1): 901, 2022 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35982416
5.
Patient characteristics associated with dose modifications for VRd among newly diagnosed multiple myeloma patients.
Future Oncol
; 18(36): 3983-3991, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36377712
6.
A plain language summary of daratumumab plus lenalidomide/bortezomib/dexamethasone in transplant-eligible Black patients with newly diagnosed multiple myeloma in the GRIFFIN study.
Future Oncol
; 18(40): 4443-4456, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36799429
7.
Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitors.
Bioorg Med Chem Lett
; 26(17): 4216-22, 2016 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27491708
8.
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
Blood Cancer J
; 14(1): 69, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649340
9.
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials.
Transplant Cell Ther
; 29(3): 174.e1-174.e10, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36494017
10.
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial.
Lancet Haematol
; 10(10): e825-e837, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37708911
11.
Initial surgical and clinical experience with the Nucleus CI532 slim modiolar electrode in the UK.
Cochlear Implants Int
; 20(4): 207-216, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30947632
12.
Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif.
Bioorg Med Chem Lett
; 18(9): 2865-70, 2008 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18420408
13.
Indazole-based ligands for estrogen-related receptor α as potential anti-diabetic agents.
Eur J Med Chem
; 138: 830-853, 2017 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28735214
14.
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.
Blood Cancer J
; 12(4): 63, 2022 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35418120
15.
Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep).
J Med Chem
; 58(9): 3859-74, 2015 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25850459
16.
Competing Diels-Alder reactions of activated nitroethylene derivatives and [3,3]-sigmatropic rearrangements of the cycloadducts.
Chem Commun (Camb)
; (10): 1090-1, 2002 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-12122679
17.
Cochlear implantation in a patient with combined renal and liver transplantation.
Cochlear Implants Int
; 15(6): 333-6, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24840806
18.
Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease.
Curr Top Med Chem
; 9(7): 599-610, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19689368
19.
Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer.
Expert Opin Investig Drugs
; 17(12): 1865-82, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19012502
20.
Inhibitory effect of statins on renal epithelial-to-mesenchymal transition.
Am J Nephrol
; 26(4): 381-7, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16873994